erythromycin has been researched along with mupirocin in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (15.91) | 18.7374 |
| 1990's | 12 (27.27) | 18.2507 |
| 2000's | 14 (31.82) | 29.6817 |
| 2010's | 11 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berge, JM; Berry, V; Boyd, HF; Brown, MJ; Elder, JS; Forrest, AK; Fosberry, AP; Gentry, DR; Hibbs, MJ; Jarvest, RL; Jaworski, DD; O'Hanlon, PJ; Pope, AJ; Rittenhouse, S; Sheppard, RJ; Slater-Radosti, C; Worby, A | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Eldridge, GR; Garo, E; Goering, MG; Hough, GW; Hu, JF; O'Neil-Johnson, M | 1 |
| Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
| Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
| Castanheira, M; Deshpande, LM; DiPersio, J; Jones, RN; Mendes, RE; Saubolle, MA | 1 |
| Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
| Gentry, DR; Gwynn, MN; Holmes, DJ; McCloskey, L; Rittenhouse, SF; Scangarella, N; Shawar, R | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Chan, JL; Cheung, GY; Joo, HS; Otto, M | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Bar-David, Y; Dagan, R | 1 |
| Abrahamian, LM; Feder, HM; Grant-Kels, JM | 1 |
| DeAngelis, C; Duggan, AK; Rice, TD | 1 |
| Dunne, WM; Esterly, NB; Nelson, DB | 1 |
| Leyden, JJ | 1 |
| McLinn, S | 2 |
| Britton, JW; Fajardo, JE; Krafte-Jacobs, B | 1 |
| Friedman, AD | 1 |
| Barton, LL; Friedman, AD; Schneller, DJ; Sharkey, AM; Swierkosz, EM | 1 |
| Kadam, SK | 1 |
| Eaglstein, WH; Marshall, DA; Mertz, PM; Montalvo, J; Piovanetti, Y | 1 |
| Ah Chan, M; Fetherston, J; Hague, IK; Haycock, D; Hunter, P; Kanji, K; Robertson, WD; Villiger, JW | 1 |
| Gratton, D | 1 |
| Blumer, JL; Crenshaw, D; Goldfarb, J; Lemon, E; O'Horo, J | 1 |
| Coffey, TJ; Klugman, KP; Meyers, M; Smith, A; Spratt, BG; Wasas, A | 1 |
| Jacob, LE; Udo, EE | 1 |
| Beuth, J; Pulverer, G; Schierholz, JM | 1 |
| Boelaert, J | 1 |
| Bryant, J; Gisby, J | 1 |
| George, A; Rubin, G | 1 |
| Cieślikowski, T; Nowak, T; Rózalska, M; Szewczyk, EM | 1 |
| Johnston, GA; Sladden, MJ | 1 |
| Choi, EC; Kim, H; Kwon, AR; Shim, MJ; Yoon, EJ; Yoon, JM | 1 |
| Buchholz, TJ; Håkansson, K; Haygood, MG; Hothersall, J; Lopanik, NB; Rath, CM; Sherman, DH; Shields, JA; Thomas, CM | 1 |
| Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
| Berger, M; Butler, CC; Koning, S; Morris, AD; van der Sande, R; van der Wouden, JC; van Suijlekom-Smit, LW; Verhagen, AP | 1 |
| Eichelmann-Herrera, K; González-González, JG; Ocampo-Candiani, J; Rodríguez-Gutiérrez, R | 1 |
| Lanier, J; Qui, MK; Shim, J | 1 |
| Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
| Durham, CO; Smith, W; VanRavenstein, K; Williams, TH | 1 |
5 review(s) available for erythromycin and mupirocin
| Article | Year |
|---|---|
Is penicillin still the drug of choice for non-bullous impetigo?
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Impetigo; Mupirocin; Penicillins; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes | 1991 |
A systematic review and meta-analysis of treatments for impetigo.
Topics: Administration, Topical; Adolescent; Algorithms; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Family Practice; Fusidic Acid; Humans; Impetigo; Infant; Infant, Newborn; Mupirocin; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
Current options for the treatment of impetigo in children.
Topics: Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Erythromycin; Fusidic Acid; Humans; Impetigo; Infant; Mupirocin; Randomized Controlled Trials as Topic; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus; Streptococcus pyogenes | 2005 |
Interventions for impetigo.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Erythromycin; Fusidic Acid; Humans; Impetigo; Mupirocin; Penicillins; Randomized Controlled Trials as Topic | 2012 |
Clinical inquiry: what is the best treatment for impetigo ?
Topics: Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Bridged Bicyclo Compounds, Heterocyclic; Cephalexin; Clindamycin; Cloxacillin; Dicloxacillin; Diterpenes; Erythromycin; Fusidic Acid; Gentamicins; Humans; Impetigo; Meta-Analysis as Topic; Mupirocin; Randomized Controlled Trials as Topic | 2014 |
12 trial(s) available for erythromycin and mupirocin
| Article | Year |
|---|---|
Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains.
Topics: Bacteria; Child; Child, Preschool; Double-Blind Method; Drug Resistance, Microbial; Erythromycin; Female; Humans; Impetigo; Infant; Israel; Male; Microbial Sensitivity Tests; Mupirocin; Patient Compliance; Penicillin Resistance; Staphylococcus aureus | 1992 |
Cost-effectiveness of erythromycin versus mupirocin for the treatment of impetigo in children.
Topics: Baltimore; Child; Cost-Benefit Analysis; Drug Costs; Erythromycin; Female; Humans; Impetigo; Male; Mupirocin; Patient Compliance; Patient Satisfaction | 1992 |
Impetigo.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Erythromycin; Fatty Acids; Humans; Impetigo; Infant; Mupirocin | 1991 |
Mupirocin: a new topical antibiotic.
Topics: Administration, Topical; Anti-Bacterial Agents; Drug Resistance, Microbial; Eczema; Erythromycin; Fatty Acids; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Mupirocin; Random Allocation; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.
Topics: Erythromycin; Fatty Acids; Female; Humans; Impetigo; Male; Mupirocin; Ointments; Randomized Controlled Trials as Topic; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 1990 |
Comparison of mupirocin and erythromycin in the treatment of impetigo.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Double-Blind Method; Erythromycin; Fatty Acids; Female; Humans; Impetigo; Infant; Male; Mupirocin | 1990 |
Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin.
Topics: Administration, Oral; Administration, Topical; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Microbial; Erythromycin; Fatty Acids; Female; Humans; Impetigo; Infant; Male; Mupirocin; Prospective Studies; Random Allocation; Staphylococcus aureus; Streptococcus | 1989 |
Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Child, Preschool; Erythromycin; Fatty Acids; Female; Humans; Impetigo; Male; Mupirocin; Penicillin Resistance; Random Allocation; Staphylococcus aureus; Streptococcus pyogenes | 1989 |
A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
Topics: Administration, Topical; Anti-Bacterial Agents; Child; Child, Preschool; Erythromycin; Fatty Acids; Female; Floxacillin; Humans; Infant; Male; Mupirocin; Random Allocation; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections | 1986 |
Topical mupirocin versus oral erythromycin in the treatment of primary and secondary skin infections.
Topics: Administration, Oral; Administration, Topical; Bacterial Infections; Dermatitis; Erythromycin; Fatty Acids; Humans; Mupirocin; Staphylococcal Infections | 1987 |
Topical mupirocin vs. systemic erythromycin treatment for pyoderma.
Topics: Administration, Topical; Anti-Bacterial Agents; Erythromycin; Evaluation Studies as Topic; Fatty Acids; Humans; Infant; Mupirocin; Pyoderma | 1988 |
Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo.
Topics: Administration, Oral; Administration, Topical; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clinical Trials as Topic; Erythromycin; Fatty Acids; Female; Humans; Impetigo; Infant; Male; Mupirocin; Random Allocation | 1988 |
27 other study(ies) available for erythromycin and mupirocin
| Article | Year |
|---|---|
Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens.
Topics: Abscess; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Enzyme Inhibitors; Methionine-tRNA Ligase; Quinolones; Rats; Rats, Sprague-Dawley; Staphylococcus; Staphylococcus aureus; Structure-Activity Relationship | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.
Topics: Annonaceae; Anti-Bacterial Agents; Gabon; Glycosides; Methicillin Resistance; Molecular Structure; Plant Leaves; Plants, Medicinal; Staphylococcus aureus | 2006 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Drug Resistance, Bacterial; Humans; Linezolid; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazolidinones; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2008 |
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pleuromutilins; Polycyclic Compounds; Sequence Analysis, DNA; Staphylococcus aureus | 2008 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cytotoxins; Methicillin-Resistant Staphylococcus aureus; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Virulence | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Impetigo therapy.
Topics: Anti-Bacterial Agents; Cefadroxil; Erythromycin; Fatty Acids; Humans; Impetigo; Mupirocin | 1990 |
Induction of ermC methylase in the absence of macrolide antibiotics and by pseudomonic acid A.
Topics: Anti-Bacterial Agents; Bacillus subtilis; beta-Galactosidase; Enzyme Induction; Erythromycin; Fatty Acids; Kinetics; Methyltransferases; Mupirocin; Plasmids | 1989 |
Cluster of an erythromycin-resistant variant of the Spanish multiply resistant 23F clone of Streptococcus pneumoniae in South Africa.
Topics: Adult; Carrier State; Child; Child, Preschool; Cluster Analysis; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Mupirocin; Otitis Media; Pneumococcal Infections; South Africa; Spain; Species Specificity; Streptococcus pneumoniae | 1994 |
Conjugative transfer of high-level mupirocin resistance and the mobilization of non-conjugative plasmids in Staphylococcus aureus.
Topics: Conjugation, Genetic; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; Microbial Sensitivity Tests; Mupirocin; Plasmids; Staphylococcus aureus | 1998 |
Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococci.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Erythromycin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mupirocin; Prostheses and Implants; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis | 1998 |
Importance of side effects in treating impetigo.
Topics: Child; Cost of Illness; Erythromycin; Humans; Impetigo; Mupirocin | 1992 |
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacitracin; Cephalexin; Chemistry, Pharmaceutical; Cricetinae; Erythromycin; Female; Floxacillin; Fusidic Acid; Impetigo; Male; Mice; Mupirocin; Neomycin; Penicillins; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Wound Infection | 2000 |
Plasmids of Staphylococcus cohnii isolated from the intensive-care unit.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriocins; Chloramphenicol; Ciprofloxacin; Clindamycin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Hospitals, Pediatric; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Mupirocin; Plasmids; Poland; Staphylococcus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
Activities of clindamycin, synercid, telithromycin, linezolid, and mupirocin against Gram-positive coccal strains resistant to erythromycin in Korea.
Topics: Acetamides; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Ketolides; Korea; Linezolid; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Virginiamycin | 2007 |
In vivo and in vitro trans-acylation by BryP, the putative bryostatin pathway acyltransferase derived from an uncultured marine symbiont.
Topics: Acyl Carrier Protein; Acylation; Acyltransferases; Amino Acid Sequence; Animals; Biocatalysis; Biological Products; Bryostatins; Bryozoa; Erythromycin; Macrolides; Malonates; Molecular Sequence Data; Multigene Family; Mupirocin; Open Reading Frames; Peptide Synthases; Phylogeny; Polyketide Synthases; Protein Structure, Tertiary; Pseudomonas fluorescens; Sequence Analysis, DNA; Sequence Deletion; Substrate Specificity; Symbiosis | 2008 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
Herpes zoster ophthalmicus masked by hymenoptera stings.
Topics: Acyclovir; Aged, 80 and over; Analgesics; Animals; Comorbidity; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Herpes Zoster Ophthalmicus; Humans; Hymenoptera; Insect Bites and Stings; Male; Mupirocin | 2014 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Diagnosis and management of impetigo.
Topics: Administration, Oral; Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Erythromycin; Humans; Impetigo; Mupirocin; Nurse Practitioners; Ointments; Staphylococcus aureus | 2017 |